Blake Insomnia Therapeutics Inc. Seeks Financing for Clinical Trials
17 janv. 2017 08h30 HE
|
Blake Insomnia Therapeutics, Inc.
NEW YORK, Jan. 17, 2017 (GLOBE NEWSWIRE) -- Blake Insomnia Therapeutics Inc. (OTC:BKIT) is preparing to launch a fundraising drive to complete Phase II clinical testing of its patent-pending ZLX-1...